Intravenous fosphenytoin therapy for rescue of acute trigeminal neuralgia crisis in patients awaiting neurosurgical procedures: A cross-sectional study-Reference-Cited by-同舟云学术

Intravenous fosphenytoin therapy for rescue of acute trigeminal neuralgia crisis in patients awaiting neurosurgical procedures: A cross-sectional study

Published:2021-12 Issue: Volume:94 Page:59-64
ISSN:0967-5868
Container-title:Journal of Clinical Neuroscience
language:en
Short-container-title:Journal of Clinical Neuroscience

Author:

Noro Shusaku,Seo Yoshinobu,Honjo Kaori,Okuma Masahiro,Asayama Bunsho,Amano Yuki,Kyono Masanori,Sako Kazuya,Nakamura Hirohiko

Publisher

Elsevier BV

Subject

Physiology (medical),Neurology (clinical),Neurology,General Medicine,Surgery

Reference13 articles.

1. A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia;Moore;Br J Anaesth,2019

2. European Academy of Neurology guideline on trigeminal neuralgia;Bendtsen;Eur J Neurol,2019

3. Headache Classification Committee of the International Headache Society (IHS) the International Classification of Headache Disorders;Jensen;Cephalalgia,2018

4. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia;Bendtsen;Lancet Neurol,2020

5. Trigeminal neuralgia: new classification and diagnostic grading for practice and research;Cruccu;Neurology,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Status trigeminal neuralgia”: Analysis of 39 cases and proposal for diagnostic criteria;Revue Neurologique;2024-09

2. Trigeminal Neuralgia;Atlas of Common Pain Syndromes;2024

3. Medical Treatment in Trigeminal Neuralgia;Trigeminal Neuralgia;2023

4. Microvascular Decompression for Concurrent Trigeminal Neuralgia and Hemi-Laryngopharyngeal Spasm: A Case Report;Operative Neurosurgery;2022-11-02

5. Intravenous Fosphenytoin Therapy as an Acute Rescue Treatment for Glossopharyngeal Neuralgia Crisis in Patients Awaiting Neurosurgical Procedures: A Case Series;Clinical Neuropharmacology;2022-09